This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hmitou, I.
Right arrow Articles by Eychène, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hmitou, I.
Right arrow Articles by Eychène, A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2007, p. 31-43, Vol. 27, No. 1
0270-7306/07/$08.00+0     doi:10.1128/MCB.01265-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Differential Regulation of B-Raf Isoforms by Phosphorylation and Autoinhibitory Mechanisms{triangledown}

Isabelle Hmitou,1,2,{ddagger} Sabine Druillennec,1,2,{ddagger} Agathe Valluet,1,2 Carole Peyssonnaux,1,2,{dagger} and Alain Eychène1,2*

Institut Curie, Centre de Recherche, Orsay F-91405, France,1 CNRS, UMR 146, Orsay F-91405, France2

Received 12 July 2006/ Returned for modification 15 August 2006/ Accepted 16 October 2006

The B-Raf proto-oncogene encodes several isoforms resulting from alternative splicing in the hinge region upstream of the kinase domain. The presence of exon 8b in the B2-Raf8b isoform and exon 9b in the B3-Raf9b isoform differentially regulates B-Raf by decreasing and increasing MEK activating and oncogenic activities, respectively. Using different cell systems, we investigated here the molecular basis of this regulation. We show that exons 8b and 9b interfere with the ability of the B-Raf N-terminal region to interact with and inhibit the C-terminal kinase domain, thus modulating the autoinhibition mechanism in an opposite manner. Exons 8b and 9b are flanked by two residues reported to down-regulate B-Raf activity upon phosphorylation. The S365A mutation increased the activity of all B-Raf isoforms, but the effect on B2-Raf8b was more pronounced. This was correlated to the high level of S365 phosphorylation in this isoform, whereas the B3-Raf9b isoform was poorly phosphorylated on this residue. In contrast, S429 was equally phosphorylated in all B-Raf isoforms, but the S429A mutation activated B2-Raf8b, whereas it inhibited B3-Raf9b. These results indicate that phosphorylation on both S365 and S429 participate in the differential regulation of B-Raf isoforms through distinct mechanisms. Finally, we show that autoinhibition and phosphorylation represent independent but convergent mechanisms accounting for B-Raf regulation by alternative splicing.

* Corresponding author. Mailing address: Institut Curie-Recherche, Laboratoire 110, Centre Universitaire, 91405 Orsay Cédex, France. Phone: 33-1 69 86 30 74. Fax: 33-1 69 07 45 25. E-mail: Alain.Eychene{at}curie.u-psud.fr.

{triangledown} Published ahead of print on 30 October 2006.

{ddagger} These authors contributed equally to this work.

{dagger} Present address: Division of Biological Sciences, University of California, San Diego, 9500 Gilman Drive, MC-0377, La Jolla, CA 92093-0377.

Molecular and Cellular Biology, January 2007, p. 31-43, Vol. 27, No. 1
0270-7306/07/$08.00+0     doi:10.1128/MCB.01265-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»